Halozyme Therapeutics Welcomes Jim Daly Back to Its Board of Directors #USA #San_Diego #Halozyme_Therapeutics #ENHANZE #Jim_Daly

Halozyme Therapeutics Launches $1.3 Billion Senior Notes Offering with Enhanced Terms #USA #San_Diego #Halozyme_Therapeutics #ENHANZE_Technology #Convertible_Senior_Notes

Halozyme Therapeutics Announces a $1.05 Billion Convertible Senior Notes Offering Set for 2033 #United_States #San_Diego #Convertible_Notes #Halozyme_Therapeutics #ENHANZE